Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.

Konishi, Yoshinobu; Takahashi, Satoshi; Nishi, Katsuyuki; Sakamaki, Taro; Mitani, Sachiko; Kaneko, Hitomi; Mizutani, Chisato; Ukyo, Naoya; Hirata, Hirokazu; Tsudo, Mitsuru

Konishi, Yoshinobu; Takahashi, Satoshi; Nishi, Katsuyuki; Sakamaki, Taro; Mitani, Sachiko; Kaneko, Hitomi; Mizutani, Chisato; Ukyo, Naoya; Hirata, Hirokazu; Tsudo, Mitsuru.

Affiliation

Konishi Y; Department of Hematology, Osaka Red Cross Hospital.

Tohoku J Exp Med ; 236(4): 289-95, 2015 08.

Article in En | MEDLINE | ID: mdl-26250536

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Castleman Disease/drug therapy; Castleman Disease/pathology; Cyclosporine/therapeutic use; Rituximab/therapeutic use; Aged; Antibodies, Monoclonal, Humanized/pharmacology; Cyclosporine/pharmacology; Edema/pathology; Female; Fever/drug therapy; Fever/pathology; Humans; Interleukin-2/antagonists & inhibitors; Platelet Count; Renal Insufficiency/pathology; Rituximab/pharmacology; Syndrome; Thrombocytopenia/pathology; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Castleman Disease / Cyclosporine / Antibodies, Monoclonal, Humanized / Rituximab Limits: Aged / Female / Humans Language: En Journal: Tohoku J Exp Med Year: 2015 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google